Stocks › HURA
TuHURA Biosciences, Inc./NV
HURA·Nasdaq·
United States·USD
United States·USD$1.95
+0.08 (+4.28%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
HURA
TuHURA Biosciences, Inc./NV · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HURAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HURA by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Laurel M. LeeHouse · R · FL |
HURATuHURA Biosciences, Inc./NV · Stock |
Purchase $50,001 - $100,000 |
Aug 9, 2025 | Jul 13, 2025 | Filing ↗ |
| Laurel M. LeeHouse · R · FL |
HURATuHURA Biosciences, Inc./NV · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2025 | Nov 25, 2024 | Filing ↗ |
| Laurel M. LeeHouse · R · FL |
HURATuHURA Biosciences, Inc./NV · Cash |
Purchase $100,001 - $250,000 |
May 25, 2024 | May 6, 2024 | Filing ↗ |
Whale Activity
Position changes in HURA reported for 2026-06-30 by 5 tracked institutional filers
- Increased1
- New2
- Held0
- Decreased1
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $5.3M | increased |
| BlackRock, Inc. | 690.1K | $1.6M | decreased |
| MILLENNIUM MANAGEMENT LLC | 454.5K | $1.1M | new |
| CITADEL ADVISORS LLC | 232.3K | $544K | new |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HURA insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
1 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Bianco James A.Chief Executive Officer · Director | Gift | −150.0K | $0.00 | $0 | May 28, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HURA · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.7M | $4.1M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iSHARES TRUST | 963.2K | $1.7M | 0.00% | Mar 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 447.7K | $1.0M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 428.5K | $960K | 0.00% | Apr 30, 2026 |
| iShares Russell 2000 Growth ETF iSHARES TRUST | 356.5K | $638K | 0.01% | Mar 31, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 219.3K | $496K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 206.6K | $467K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF iShares Trust | 163.7K | $383K | 0.03% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 98.9K | $222K | 0.00% | Apr 30, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 76.3K | $173K | 0.00% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list HURA's shares (CUSIP 898920103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming TuHURA Biosciences, Inc./NV as client
No lobbying filings found naming TuHURA Biosciences, Inc./NV as the client.
Government Contracts
Federal awards to TuHURA Biosciences, Inc./NV · USAspending
No federal contract awards found for TuHURA Biosciences, Inc./NV.
U.S. Patents
Recent USPTO applications naming TuHURA Biosciences, Inc./NV
No USPTO patent applications found for TuHURA Biosciences, Inc./NV.
Annual Financials
From HURA's 10-K filings · XBRL
No annual XBRL figures on record for HURA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-35Reverse splitOct 18, 2024
- 1-for-50Reverse splitNov 14, 2022
- 1-for-10Reverse splitMay 8, 2019
- 1-for-4Reverse splitMay 20, 2016
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.03, 9.01Direct financial obligationSep 24, 2026
EDGAR ↗ - 8-K · Items 2.03, 9.01Direct financial obligationSep 17, 2026
EDGAR ↗ - 8-K/A · Items 5.02, 9.01Officer / director changeSep 17, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeSep 16, 2026
EDGAR ↗ - 8-K · Items 2.03, 9.01Direct financial obligationSep 4, 2026
EDGAR ↗ - 8-K · Items 2.03, 9.01Direct financial obligationAug 21, 2026
EDGAR ↗ - 8-K · Items 3.02, 5.07, 9.01Unregistered sale of equity · Shareholder voteAug 19, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 14, 2026
EDGAR ↗ - 8-K · Items 2.03, 9.01Direct financial obligationAug 13, 2026
EDGAR ↗ - 8-K · Items 2.03, 9.01Direct financial obligationJul 29, 2026
EDGAR ↗
About TuHURA Biosciences, Inc./NV
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTAMPA, FL
IncorporatedNV
SEC CIK0001498382 ↗
Former namesKintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.